India Calls for Quick Data on Pharma Exports to Pakistan

In the face of growing tensions in bilateral trade relations, the Department of Pharmaceuticals (DoP) has requested the Pharmaceuticals Export Promotion Council of India (Pharmexcil) to prepare a comprehensive list of medicines and pharmaceuticals...

FDA Review of Novavax COVID Vaccine Raises Doubts about Broader Shot Approval

On Monday, the Food and Drug Administration (FDA) asked Novavax to run a new clinical trial of its vaccine after the agency granted full approval.

ISRO & SCTIMST Partners to deliver Advanced Space Medicine in India

An innovation in Space Medicine has been made through the partnership of the Indian Space Research Organisation (ISRO), Sree Chitra Tirunal Institute for Medical Sciences and Technology (SCTIMST),and the Department of S...

Dengue Vaccine 'Qdenga' Set for India Launch in 2026

In India 2026, a Japanese major Takeda, plans to launch a vaccine for dengue, Qdenga, to align with the ‘Make-in-India’, partnering with Hyderabad-based Biological E (Bio E).

Roche's Risdiplam Profits Spark Pricing Debate in India

Pharmaceutical giant Roche is said to have earned profits exceeding a hundredfold the estimated price of taking its spinal muscular atrophy (SMA) medication, risdiplam, to India. Public health organization Knowledge Ecology International (KEI) put...

Piyush Goyal Takes Critical Stance against Evergreening of Patients

In the World Health Summit (WHS) Regional Meeting Asia 2025, Piyush Goyal, Minister of Commerce & Industry criticized pharmaceutical companies for making their patent evergreen. The summit was held in Delhi’s Bharat Manda...

Dr. Reddy's Plans Global GLP-1 Launch as Patents Expire

Dr. Reddy's Laboratories is preparing to enter the rapidly expanding GLP-1 (glucagon-like peptide-1) drug market, hoping to launch generic versions of key diabetes and obesity drugs such as Semaglutide...

Novavax Faces Demand for COVID-19 Vaccine Clinical Trial

The US FDA requests that Novavax finish a new clinical trial for the postponed COVID-19 vaccination. The WSJ reports According to persons familiar with the situation, the Wall Street Journal said Friday that federal

Indian Multinational Pharma Firm Zydus Lifesciences gets 85.6 % Stake in Amplitude Surgical

Amplitude Surgical SA (Amplitude) and Zydus Lifesciences Limited (Zydus) attest that Amplitude has consulted with Amplitude SAS's works council and provided the required information. As a result, Zydus has agreed to buy 75.4 percent

CDSCO Approves Entod Pharma's Myopia-control Eye Drop for Children

The Central Drugs Standard Control Organization (CDSCO) has granted marketing authorization to Entod Pharmaceuticals, a multinational research-driven ophthalmic firm, for a novel ocular formulation designed

© 2025 India Pharma Outlook. All Rights Reserved.